Covid could be a Waterloo for the leading bioethical theory


Napoleon gallops towards Waterloo 

Covid-19 is providing a stress test for bioethical theories. And it seems that not all varieties will succeed. Writing from a utilitarian perspective, the co-editor of the journal Bioethics, Udo Schüklenk, and an Irish bioethicist, John Lawrence, have delivered a stinging critique of the dominant paradigm in contemporary bioethics, principlism.

They examined a number of Covid-19 policy documents to see whether they provided useful guidance for doctors and policy makers. The answer, they believe, is No.:

On each occasion a number of well‐sounding principles, that most reasonable people would have great difficulty finding fault with, are added—as a kind of preface—to what would otherwise be highly controversial policy documents. These principles are typically in conflict (think autonomy and beneficence, or utility and equity). It is unclear how they relate to each other. And, in cases where two or more principles result in conflicting action guidance, we are no clearer about which of them ought to be prioritized. Most importantly, such principles do not, when specified to the degree that they tend to be in ethical guidelines, provide a clear‐cut and conclusive answer to the question of who, in the here and now, should be offered treatment or a vaccine when it is not possible to treat or vaccinate all those who could benefit.

As a result of the conceptual chaos, Covid-era bioethics is returning to the bad old days of “doctor knows best”.

In the absence of explicit criteria for weighing and balancing competing ethical demands, one ends up with a guidance document that is unable to provide any explicitly justifiable ethical guidance to begin with. The result is that health care providers and practitioners are left to make adjudications and trade‐offs on their own.

Michael Cook is editor of BioEdge




MORE ON THESE TOPICS | bioethics, principlism

This article is published by Michael Cook and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 
comments powered by Disqus